We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

179 hedge funds and large institutions have $1.21B invested in Sarepta Therapeutics in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 44 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $108M | Put options by funds: $54.9M

45% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 44

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

11% more capital invested

Capital invested by funds: $1.08B → $1.21B (+$123M)

2.09% more ownership

Funds ownership: 72.29% → 74.38% (+2.1%)

1% more funds holding

Funds holding: 177 → 179 (+2)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
179
Holders Change
+2
Holders Change %
+1.13%
% of All Funds
4.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
39
Increased
64
Reduced
44
Closed
28
Calls
$108M
Puts
$54.9M
Net Calls
+$53.5M
Net Calls Change
+$36.4M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$160M
2
HM
HealthCor Management
New York
+$48M
3
CCM
Camber Capital Management
Massachusetts
+$41.8M
4
O
OrbiMed
New York
+$32.6M
5
PC
PointState Capital
New York
+$19.8M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$62.4M
2
PA
Perceptive Advisors
New York
-$30.9M
3
ACA
Avoro Capital Advisors
New York
-$27.7M
4
JG
Jefferies Group
New York
-$26M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
51
Creative Planning
Kansas
$3.29M +$365K +11,800 +12%
PPA
52
Parametric Portfolio Associates
Washington
$3.23M +$148K +4,785 +5%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$2.92M -$142K -4,600 -4%
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$2.92M +$30.8K +996 +1%
Barclays
55
Barclays
United Kingdom
$2.84M +$499K +16,109 +20%
Wolverine Trading
56
Wolverine Trading
Illinois
$2.82M +$3.01M +97,175 New
GC
57
Guggenheim Capital
Illinois
$2.59M +$52.7K +1,704 +2%
ACM
58
Asymmetry Capital Management
California
$2.58M +$2.7M +87,180 New
Renaissance Technologies
59
Renaissance Technologies
New York
$2.55M +$1.15M +37,000 +75%
Swiss National Bank
60
Swiss National Bank
Switzerland
$2.53M +$99K +3,200 +4%
Wells Fargo
61
Wells Fargo
California
$2.51M +$514K +16,620 +24%
CWG
62
C WorldWide Group
Denmark
$2.45M +$2.46M +79,431 +2,404%
UBS Group
63
UBS Group
Switzerland
$2.41M -$357K -11,529 -12%
Tudor Investment Corp
64
Tudor Investment Corp
Connecticut
$2.4M +$2.5M +80,929 New
PC
65
Paulson & Co
New York
$2.31M +$2.42M +78,101 New
AllianceBernstein
66
AllianceBernstein
Tennessee
$2.15M – – –
Citigroup
67
Citigroup
New York
$2.05M +$1.28M +41,476 +149%
PAMU
68
Pictet Asset Management (UK)
United Kingdom
$2M +$415K +13,400 +25%
Bank of America
69
Bank of America
North Carolina
$1.9M +$28.5K +922 +1%
Allianz Asset Management
70
Allianz Asset Management
Germany
$1.89M +$95.4K +3,084 +5%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.78M +$64.4K +2,082 +4%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.57M +$31 +1 +0%
AQR Capital Management
73
AQR Capital Management
Connecticut
$1.55M +$330K +10,648 +26%
Simplex Trading
74
Simplex Trading
Illinois
$1.41M +$1.47M +47,481 New
HighTower Advisors
75
HighTower Advisors
Illinois
$1.38M +$162K +5,225 +13%
1 2
3
4 5

SRPT Hedge Fund Activity: Q1 2017 in Review

179 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q1 2017, worth a combined $1.21B — up 11% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SRPT positions and 28 closed out — a net gain of 11 holders — while 64 added to existing stakes and 44 trimmed.

The largest buyer was BlackRock, adding an estimated $160M. The largest seller was Sabby Management, exiting entirely with an estimated $62.4M sold.

  • 179 institutional investors held Sarepta Therapeutics (SRPT) as of Q1 2017, up from 177 in Q4 2016.
  • Funds reported $1.21B of Sarepta Therapeutics stock for Q1 2017, up 11% quarter-over-quarter.
  • 39 funds opened new Sarepta Therapeutics positions in Q1 2017 and 28 closed out, a net change of +11 holders.
  • The largest Sarepta Therapeutics buyer in Q1 2017 was BlackRock, an estimated $160M added.
  • The largest Sarepta Therapeutics seller in Q1 2017 was Sabby Management, an estimated $62.4M sold.

Based on aggregated 13F filings for Q1 2017.